| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.3 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.3 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.3 |